Abstract
Introduction

Polyarteritis nodosa is a multi-system, necrotizing vasculitis of medium-sized arteries. In humans, the involvement of the visceral and renal arteries is characteristic. In the pathogenesis of polyarteritis nodosa, a role of viral antigens is documented for the hepatitis B virus (HBV)-positive type, which is seen as a distinct form of polyarteritis nodosa and is treated with anti-viral therapy
. The pathogenesis of the HBV-negative forms of polyarteritis nodosa is still unknown.
Patients usually present with weakness, malaise, weight loss, headache, abdominal pain, testicular pain and myalgias. Despite improvements in the therapy of polyarteritis nodosa, about 10% of patients still die from fulminant polyarteritis, with a median survival time of 3 months after diagnosis [2] . In more than 30% of the patients, hypertension is observed. Cases have been reported with renin-dependent hypertension. In these cases, hypertension was believed to be secondary to polyarteritis-associated inflammation of renal arteries [3] [4] [5] .
Recently, the cyp1a1ren-2 transgenic rat has been generated as a transgenic model of renin-dependent hypertension [6] . In these rats, occasionally, cases have been observed with nodular infiltration of mesenteric vessels, as is typical for polyarteritis nodosa (Peters, B. unpublished [7] . 
observations). In cyp1a1ren-2 transgenic rats, the expression of the ren-2 renin transgene is under the control of the promoter of the cyp1a1 gene, which can be activated by oral administration of various xenobiotics, including the non-toxic aryl hydrocarbon compound indole-3-carbinol (I3C). Thus, the model permits the induction of renin expression predominantly in the liver. The administration of I3C results in dose-dependent elevations of plasma prorenin levels
Blood sampling and determinations of renin, prorenin and autoantibodies
On the day before induction and after 3 and 6 weeks, 1.5 ml of ethylenediaminetetraacetic acid (EDTA)-blood were collected from the retro-orbital plexus under light ether anaesthesia. Plasma active renin (PRC) levels were determined enzymatically by the capacity of the enzyme to generate angiotensin I (Ang I), as described previously [12] . Plasma prorenin levels were determined after trypsin activation [12] . Serum 
Results
Increase of blood pressure by I3C and its prevention by captopril
In cyp1a1ren-2 transgenic rats, prorenin-dependent hypertension was induced. Without I3C treatment, the blood pressure in cyp1a1ren-2 transgenic rats was in the normal range and was stable (TM: 105Ϯ11 mmHg, the average of 10 weeks; Fig. 1 ). In I3C-treated rats (TMϩI3C), the mean arterial pressure increased continuously until it reached a plateau of about 170 mm Hg at week 6 (Fig. 1) (Fig. 3B) . Together with the celiac artery, the arteries of the pancreas were affected (Fig. 3C) Fig. 5C ) and was absent in the groups of Con rats (Fig. 5A ) and I3C rats (Fig. 5B) . In an independent experiment (groups: Con, I3C: (Fig. 5D ) nor did the rats that were shamoperated (Sham TMϩI3C; Fig. 5E ).
0.125% and TMϩI3C, n ϭ 5 each), all TMϩI3C rats, but none of the Con or I3C rats, developed polyarteritis nodosa (see Supporting Information). Thus, in our model, polyarteritis nodosa was reproducibly induced by I3C treatment combined with chronic instrumentation (TMϩI3C: 10 out of 11 rats). Telemetric devices are frequently used in hypertension research. To exclude that polyarteritis nodosa was related to the device, six rats received a catheter without induction of the renin-angiotensin system (TM). None of these rats developed polyarteritis nodosa
To investigate whether the development of polyarteritis nodosa is influenced by the renin-angiotensin system, six rats received catheters and were treated with I3C as well as with captopril (TMϩI3CϩCap). The oral administration of captopril at a final dose of 25 mg/100 ml of drinking water completely prevented the development of polyarteritis nodosa (Figs 5F and 6 (bottom)).
At the same time, five out of six TMϩI3C rats developed severe polyarteritis nodosa (Fig. 5C ).
Absence of ANCA and ANA
Blood serum was obtained from the rats in all groups at the end of the experiment. All sera were negative for ANCA and ANA. 27 , severe phenotypes were observed with proteinuria, fibrosis of the heart, myocardial infarction and early death [13] [14] [15] . The predominantly affected vessels are the renal and coronary arteries. With high doses of I3C, cyp1a1ren-2 transgenic rats develop malignant hypertension with glomerulosclerosis and cardiac microinfarctions after 2 weeks of induction. Under these conditions, fibrinoid necrosis of the mesenteric vessels occurred, which was seen as a premature state of hypertension-induced endangiitis obliterans [6] . In the present study, lower doses of I3C were applied, leading to only moderate non-malignant hypertension and thus allowing us to study the rats for a longer period of time than in the previous studies. The coronary and cerebral arteries only showed thickening of the media as a sign of hypertensive vasculopathy. The mesenteric lesions seen in the present study are typical for polyarteritis nodosa rather than for hypertension-induced endorgan damage. These lesions require several weeks to develop and may have escaped detection in shorter-lasting studies. As in the human macroscopic form of polyarteritis nodosa, affected vessels were medium-sized arteries and the sera were negative for ANCA and ANA. At present, no information is available, however, about cryoglobulins, which also are negative in human macroscopic polyarteritis nodosa.
Prorenin is necessary but not sufficient to induce polyarteritis
(A) Immunohistochemistry of mesenteric polyarteritis lesions with anti-CD3 (DAB staining). Positively stained cells are labelled brown. (B) Chloracetate esterase reaction of mesenteric polyarteritis lesions for the identification of polymorphic leucocytes (red
Discussion
The pathogenesis of the hepatitis B-negative form of polyarteritis nodosa is currently unknown. Here, we demonstrate that necrotizing vasculitis resembling classical polyarteritis nodosa can be reproducibly induced by the activation of the renin-angiotensin system under defined conditions (the PAN-cyp1a1ren-2 transgenic model). Furthermore, we show that polyarteritis nodosa in this model can be prevented by the angiotensin-converting enzyme inhibitor captopril.
Fig. 5 Captopril prevented the development of polyarteritis nodosa. Representative tissue sections (same magnification) of the mesenteric vessels of cyp1a1ren-2 rats (haematoxylin and eosin staining). (A) control rats, (B) I3C-treated rats (I3C), (C) I3C-treated rats with transmitter (TM ϩ I3C), (D) transmitter-implanted rats (TM), (E) sham-operated rats treated with I3C (Sham TM ϩ I3C) and (F) co-application of I3C and captopril to transmitterimplanted rats (TM ϩ I3C ϩ Cap). Bar ϭ 250 m.
In transgenic models of angiotensin-induced end-organ damage such as dTGR (human angiotensin and human renin gene transgenic) or TGR(mRen2)
The activation of the renin-angiotensin system and the subsequent development of arterial hypertension are frequent sequelae of polyarteritis nodosa. In this context, renin is believed to be released, because of the vasculitis and a subsequent stenosis of the renal arteries [2, 4] . [20] .
Necrotizing vasculitis in rats has been observed under treatment with various vasoactive compounds such as theophylline [21] , endothelin receptor antagonists, fenoldopam [22] and selective phosphodiesterase type 3 (PDE3) [23] as well as PDE4 inhibitors [24] . These compounds have in common that they can induce systemic hypotension and it has been proposed that this may lead to decreased oxygen delivery, necrosis, enhanced endothelial permeability, protein exudation and immigration of inflammatory cells [25] . It should be noted that all these components also stimulate renin release [26] [27] [28] [29] [30] . Up-regulation of the local vascular renin-angiotensinaldosterone system during monocyte differentiation to macrophages may amplify monocyte migration into the vessel wall [31] . Recently, it has been demonstrated that T cells possess a functional renin-angiotensin system [32] and are capable of producing and delivering Ang II to sites of inflammation. In the present study, vascular lesions were infiltrated with polymorphic leucocytes and T cells. As Ang II induces the recruitment of inflammatory cells [33] and promotes the secretion of the chemokine CCL5/RANTES by natural killer (NK) and T cells [34] 
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